ArticleAngewandte Chemie (International ed. in English)2025
Total Synthesis of Feglymycin Using Umpolung Amide Synthesis.
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Recognition of a Conserved Minimal Catalaphile Explains Catalyst Generality in Enantioselective Nitroalkene Reductions.ACS catalysis · 2026Article
- Total Synthesis of Feglymycin Using Umpolung Amide Synthesis.Angewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The preparation of peptidic molecules is a mainstay of synthesis, creating new tools that advance chemical biology, catalysis, and drug discovery. Despite the wide adoption of methods for amide synthesis based on electrophilic acyl transfer reactions, significant limitations remain that restrict access to chemical space and plague accessible peptides with imperfect conservation of stereochemical information. These problems persist in key applications (i.e., solid phase peptide synthesis) where reagent excess can be used to drive maximal yield. As a general tactic, however, use of excess coupling agents that are often hazardous is unsustainable. Here we report the synthesis of the antiviral tridecapeptide feglymycin where half of the amides are formed using umpolung amide synthesis (UmAS) to replace conventional amide synthesis. Reliance on UmAS further allowed the enantioselective synthesis of each noncanonical residue from an inexpensive aldehyde. As a result, the most process-intensive components were simplified to a chiral Brønsted acid organocatalyst and potassium iodide/urea·hydrogen peroxide (KI/UHP). This solution-phase total synthesis illustrates the harmonious, strategic application of complementary amide synthesis methods, and it serves as a touchstone for the green synthesis of peptides composed of noncanonical amino amides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.